top of page
.png)
Onco-Summaries: Daily Oncology Updates at a Glance
22/07/2025 Replimune's BLA for vusolimogene oderparepvec + nivo received a CRL from the US FDA ( Ref ) The US FDA issued a Complete...
Oncofocus Team
Jul 231 min read
Â
FDA Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests
📢 The U.S. FDA launched a new program - the Commissioner’s National Priority Voucher (CNPV) - to shorten review timelines from 10-12...
Oncofocus Team
Jun 191 min read
Â
bottom of page